Management of Stable COPD: An Update

Author(s): Alexandru Corlateanu, Gloria Montanari, Alexandros G. Mathioudakis, Victor Botnaru, Nikolaos Siafakas

Journal Name: Current Respiratory Medicine Reviews

Volume 9 , Issue 6 , 2013

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Chronic Obstructive Pulmonary Disease (COPD), being a major cause of morbidity and mortality worldwide, is a major problem for public health. It is predicted that its burden will continuously expand over the next years. This article is an up-to-date review of both non-pharmacologic and pharmacologic management of COPD, which is now based on new staging systems, able to predict prognosis and the response to different treatment approaches. Non-pharmacologic therapies, such as smoking cessation, vaccinations and pulmonary rehabilitation are covered briefly. Current pharmacologic management covers short acting beta-agonists (SABA), short acting muscarinic antagonists (SAMA), long acting beta agonists (LABA), long acting antimuscarinics (LAMA), inhaled corticosteroids (ICS), LABA/ICS combinations, xanthines, specific phosphodiesterase 4 (PDE4) inhibitors and oxygen therapy.

Keywords: Chronic obstructive pulmonary disease (COPD), disease management, pharmacotherapy, phenotypes, rehabilitation.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [352 - 359]
Pages: 8
DOI: 10.2174/1573398X10666140222001646
Price: $65

Article Metrics

PDF: 31